| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |